Search Login Register

Meige Syndrome Summary

Description: A syndrome characterized by orofacial DYSTONIA; including BLEPHAROSPASM; forceful jaw opening; lip retraction; platysma muscle spasm; and tongue protrusion. It primarily affects older adults, with an incidence peak in the seventh decade of life. (From Adams et al., Principles of Neurology, 6th ed, p108)

Also Known As: Blepharospasm-Oromandibular Dyskinesia; Blepharospasm-Oromandibular Dystonia Syndrome; Blepharospasm-Oromandibular Dystonia Syndrome, Idiopathic; Idiopathic Blepharospasm-Oromandibular Dystonia Syndrome; Syndrome, Blepharospasm-Oromandibular Dystonia Show All >>

Networked: 60 relevant articles (7 outcomes, 2 trials/studies) for this Disease

Key Drugs and Agents for Meige Syndrome

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Botulinum Toxins (Botulinum Toxin) : 5 outcomes 1 study in 17 results : IBA
  2. Benign essential blepharospasm : 2 outcomes in 5 results : IBA
  3. Antipsychotic Agents (Antipsychotics) : 1 outcome in 2 results : IBA
  4. pantogab (hopantenic acid) : 1 outcome in 1 result : IBA
  5. Vigabatrin : 1 study in 1 result : FDA 2
  6. Type A Botulinum Toxins (Botulinum A Toxin) : 3 results : FDA 2
  7. Trihexyphenidyl (Artane) : 2 results : FDA 16 Generic
  8. Lisuride : 2 results : IBA
  9. Clonazepam (Rivotril) : 2 results : FDA 16 Generic
  10. Congenital hereditary lymphedema : 2 results : IBA
Show All >>

Diseases Related to Meige Syndrome

  1. Blepharospasm
  2. Dystonia (Limb Dystonia)
  3. Hemifacial Spasm
  4. Dyskinesias (Dyskinesia)
  5. Torticollis (Wryneck)
Show All >>

Key Therapies for Meige Syndrome

Efficacy Chart >>
  1. Injections : 1 outcome 1 study in 9 results
  2. Drug Therapy (Chemotherapy) : 1 outcome in 2 results
  3. Deep Brain Stimulation : 11 results
  4. Pallidotomy : 2 results
  5. Intravenous Infusions : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.